Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist

Pharmazie

Volumn 66, Issue 6, 2011, Pages 436-439

  Dong, Mei ^a   Huang, Lili ^a   Wang, Wenjun ^a   Du, Miaomiao ^a   He, Zuanyu ^a   Mo, Yaqin ^a   Yang, Dongzi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; MESSENGER RNA; MUELLERIAN INHIBITING FACTOR; STEM CELL FACTOR; TRIPTORELIN;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; OOCYTE; OVARIAN RESERVE; OVARY FOLLICLE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANTI-MULLERIAN HORMONE; BLOTTING, WESTERN; FEMALE; GONADOTROPIN-RELEASING HORMONE; GRANULOSA CELLS; HORMONE ANTAGONISTS; HUMANS; INDICATORS AND REAGENTS; LUTEOLYTIC AGENTS; OVARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELL FACTOR; TRIPTORELIN;

EID: 79959985640     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0847     Document Type: Article

References (41)

1. Ataya K, Rao LV, Lawrence E, Kimmel R (1995) Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 52: 365-372.
2. Blumenfeld Z (2003) Gynecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol 15: 359-370.
3. Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM (2002) Fertility after treatment for Hodgkin's disease. Ann Oncol 13 (suppl 1): 138-147. (Pubitemid 34567418)
4. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O (2006) Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Human Reproduction.21: 2223-2227. (Pubitemid 44530593)
5. Chegini N, Ma C, Tang XM, Williams RS (2002) Effects of GnRH analogues, "add-back" steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-βexpression. Mol Hum Reprod 8: 1071-1078.
6. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Chou CS, MacCalman CD, Leung PC (2003) Differential effects of gonadotropin-releasing hormone I and II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human decidual stromal cells in vitro. J Clin Endocrinol Metab 88: 3806-3815. (Pubitemid 37034532)
7. Conn PM (1994) The molecular mechanism of gonadotropin-releasing hormone action in the pituitary. In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven Press, New York: 1815-1826.
8. Danforth DR, Arbogasta LK, Friedman CI (2005) Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 83: 1333-1338. (Pubitemid 40615801)
9. Durlinger ALL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen APN (2002) Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143: 1076-1084. (Pubitemid 34164056)
10. Durlinger ALL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, ThemmenAPN(1999) Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 140: 5789-5796. (Pubitemid 30645368)
11. Fauser BC, Devroey P (2005) Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril 83: 1607-11. (Pubitemid 40834230)
12. Flaws JA, Abbud R, Mann RJ, Nilson JH, Hirshfield AN (1997) Chronically elevated luteinizing hormone depletes primordial follicles in the mouse ovary. Biol Reprod 57: 1233-1237. (Pubitemid 27461218)
13. Griesinger G, Felberbaum R, Diedrich K (2005) GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German National IVF Registry. Hum Reprod 20: 2373-2375. (Pubitemid 41222479)
14. Gründker C, Schlotawa L, Viereck V, Eicke N, Horst A, Kairies B, Emons G (2004) Antiproliferative effects of the GnRH antagonist cetrorelix and anti proliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor. Eur J Endocrinol 151: 141-149. (Pubitemid 39117377)
15. Hori H, Uemura T, Minaguchi H (1998) Effects of GnRH on protein kinase C activity, Ca21 mobilization and steroidogenesis of human granulosa cells. Endocr J 45: 175-182.
16. Hoyer PE, Byskov AG, Mollgard K (2005) Stem cell factor and c-Kit in human primordial germ cells and fetal ovaries. Mol Cell Endocrinol 234: 1-10.
17. Hsueh AJ, Jones PB (1981) Extrapituitary actions of gonadotropin releasing hormone. Endocr Rev 2: 437-461.
18. Jayaprakasan K, Campbell BK, Hopkisson JF, Clewes JS, Johnson IR, Raine-Fenning NJ (2008) Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone. Hum Reprod. 23: 2577-2583.
19. Kakar S, Grantham K, Musgrove L, Devor D, Selers C, Neill J (1994) Rat gonadotropin-releasing hormone (GnRH) receptor: tissue expression and hormonal regulation of its mRNA. Mol Cell Endocrinol 101: 151-157. (Pubitemid 24132785)
20. Kang JS, Lee CJ, Lee JM, Rha JY, Song KW, Park MH (2003) Follicular expression of c-Kit/SCF and inhibin-alpha in mouse ovary during development. J Histochem Cytochem 51: 1447-1458. (Pubitemid 37444533)
21. Knight PG, Glister C (2006) TGF-beta superfamily members and ovarian follicle development. Reproduction 132: 191-206. (Pubitemid 44274724)
22. Kovacs M, Schally AV (2001) Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc Natl Acad Sci USA 98: 12197-12202. (Pubitemid 32959850)
23. Liu K (2006) Stem cell factor (SCF)-kit mediated phosphatidylinositol 3 (PI3) kinase signaling during mammalian oocyte growth and early follicular development. Front Biosci Jan 111: 126-35.
24. Lobo RA (2005) Potential options for preservation of fertility in women. N Engl J Med 353: 64-73.
25. Lutchman Singh K, Davies M, Chatterjee R (2005) Fertility in female cancer survivors: Pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 11: 69-89. (Pubitemid 40201977)
26. Mason DR, Arora K, Mertz LM, Catt KJ (1994) Homologous down-regulation of gonadotropin-releasing hormone receptor sites and messenger ribonucleic acid transcripts in aT3-1 cells. Endocrinology 135: 1165-1170. (Pubitemid 24271212)
27. Murase M, Uemura T, Gao M, Inada M, Funabashi T, Hirahara F (2005) GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects. Endocr J 52: 131-137. (Pubitemid 40410329)
28. Orvieto R, Rabinson J, Meltzer S, Homburg R, Anteby E, Zohav E (2006) GnRH agonist versus GnRH antagonist in ovarian stimulation: is the emperor naked? Clin Exp Obstet Gynecol 33: 197-199.
29. Parrott JA, Skinner MK (1999) Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 140: 4262-4271. (Pubitemid 30647125)
30. Peng P, Yang DZ, Zheng CY, Mo YQ, He YM, Zhang QX (2007) Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 42: 546-550.
31. Richardson SJ, Senikas V, Nelson JF (1987) Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65: 1231-1237. (Pubitemid 18026863)
32. Robinson LL, Sklar CA (2006) Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 91: 1723-1728.
33. Schwartz CL (1999) Long-term survivors of childhood cancer: The late effects of therapy. Oncologist 4: 45-54.
34. Sim PJ, Wolbers WB, Mitchell R (1995) Activation of MAP kinase by the LHRH receptor through a dual mechanism involving protein kinase C and a pertussis toxin-sensitive G protein. Mol Cell Endocrinol 112: 257-263.
35. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL (2006) Premature menopause in survivors of childhood cancer: Areport from the childhood cancer survivor study. J Natl Cancer Inst 98: 890-896. (Pubitemid 44018918)
36. Sonmezer M, Oktay K. (2006) Fertility preservation in youngwomen undergoing breast cancer therapy. Oncologist 11: 422-434. (Pubitemid 43788268)
37. Stanislaus D, Ponder S, Ji TH, Conn PM (1998) Gonadotropin-releasing hormone receptor couples to multiple G-proteins in rat gonadotrophs and in GGH3 cells: evidence from palmitoylation and overexpression of G proteins. Biol Reprod 59: 579-586. (Pubitemid 28395073)
38. Stojilkovic SS, Catt KJ (1995) Novel aspects of GnRH-induced intracellular signaling and secretion in pituitary gonadotrophs. J Neuroendocrinol 7: 739-757.
39. Suh CS, Sonntag B and Erickson GF (2002) The ovarian life cycle: a contemporary view. Rev Endocr Metab Disord 3: 5-12. (Pubitemid 34693399)
40. Tai CJ, Kang SK, Cheng KW, Choi KC, Nathwani PS, Leung PCK (2000) Expression and regulation of P2U-purinergic receptor in human granulose-luteal cells. J Clin Endocrinol Metab 85: 1591-1597. (Pubitemid 32289505)
41. Yacobi K, Wojtowicz A, Tsafriri A, Gross A (2004) Gonadotropins enhance caspase-3 and -7 activity and apoptosis in the theca-interstitial cells of rat preovulatory follicles in culture. Endocrinology 145: 1943-1951. (Pubitemid 38402404)